Special Issue "Genetic and Molecular Mechanisms of Hypertrophic Cardiomyopathy"
Deadline for manuscript submissions: 31 January 2022.
Hypertrophic cardiomyopathy (HCM) is a common inherited genetic disorder affecting approximately 1 in 500 live births, manifest as left ventricular hypertrophy without any underlying cause. The hypertrophy is often asymmetric, most commonly affecting the interventricular septum, and is often associated with left ventricular outflow tract obstruction. Associated findings include myocardial fibrosis, sudden cardiac death, microvascular ischemia, and mitral valve abnormalities. Although the majority of known mutations occur in sarcomeric genes, the pleiotropic manifestations of this disorder that occur in both myocytes and nonmyocyte tissues are not easily explained by these mutations. The majority of patients also do not have identifiable disease-causing mutations, raising questions about other genetic, epigenetic or nongenetic causes. Despite significant advances in understanding how HCM sarcomeric mutations affect sarcomere function and myocardial contractility, the downstream molecular mechanisms that lead to asymmetric hypertrophy, cardiac arrhythmias, mitral valve abnormalities, and microvascular dysfunction are poorly understood. This issue calls for studies that address current gaps in knowledge.
Prof. Dr. Michael T. Chin
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. International Journal of Molecular Sciences is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. There is an Article Processing Charge (APC) for publication in this open access journal. For details about the APC please see here. Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- hypertrophic cardiomyopathy
- cardiac hypertrophy
- cardiac fibrosis
- sudden cardiac death
- inherited cardiomyopathy
- interventricular septum
- left ventricular outflow tract obstruction
- genetic disorder